Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Bergman

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 3, 2011
The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantationR A Fisher, K D Kistler, P Ulsh, et al.
Seminars in Hematology|April 1, 1990
Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia BH C Kim, C W McMillan, G C White, et al.
American Journal of Hematology|May 1, 1995
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study GroupI Warrier, C K Kasper, G C White, et al.
Thrombosis and Haemostasis|May 1, 1995
Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study GroupG C White, A D Shapiro, E M Kurczynski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Lack of immune response to mouse IgG in previously untreated haemophilia A and haemophilia B patients treated with monoclonal antibody purified factor VIII and factor IX preparationsH M Davis, D W Nash, M D Clymer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical proceduresA D Shapiro, G C White Ii, H C Kim, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2012
Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health recordsJ Menzin, J Hoesche, M Friedman, et al.
Blood|February 1, 1992
Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentratesH C Kim, C W McMillan, G C White, et al.
Thrombosis and Haemostasis|February 10, 2012
Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health recordsJ Menzin, L A White, M Friedman, et al.
Research in Medical Education : Proceedings of the ... Annual Conference. Conference on Research in Medical Education|January 1, 1984
Visual arts training to enhance observational skills of medical studentsM H Appel, C Stegeman, R Mark, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 3, 2011
The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantationR A Fisher, K D Kistler, P Ulsh, et al.
Seminars in Hematology|April 1, 1990
Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia BH C Kim, C W McMillan, G C White, et al.
American Journal of Hematology|May 1, 1995
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study GroupI Warrier, C K Kasper, G C White, et al.
Thrombosis and Haemostasis|May 1, 1995
Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study GroupG C White, A D Shapiro, E M Kurczynski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Lack of immune response to mouse IgG in previously untreated haemophilia A and haemophilia B patients treated with monoclonal antibody purified factor VIII and factor IX preparationsH M Davis, D W Nash, M D Clymer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical proceduresA D Shapiro, G C White Ii, H C Kim, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2012
Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health recordsJ Menzin, J Hoesche, M Friedman, et al.
Blood|February 1, 1992
Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentratesH C Kim, C W McMillan, G C White, et al.
Thrombosis and Haemostasis|February 10, 2012
Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health recordsJ Menzin, L A White, M Friedman, et al.
Research in Medical Education : Proceedings of the ... Annual Conference. Conference on Research in Medical Education|January 1, 1984
Visual arts training to enhance observational skills of medical studentsM H Appel, C Stegeman, R Mark, et al.
Pageof 4